Provenge works by stimulating the body's immune system to target and attack prostate cancer cells. The process involves collecting a patient's immune cells through a procedure called leukapheresis. These cells are then exposed to a protein that is found on most prostate cancer cells, combined with an immune-stimulating agent. This process activates the immune cells to specifically target and destroy prostate cancer cells when reintroduced into the patient's body.
